Heart damage from chemo: a closer look that never got off the ground
NCT ID NCT05803889
First seen Jan 07, 2026 · Last updated Jun 23, 2026 · Updated 32 times
Summary
This study aimed to understand how common breast cancer chemotherapy drugs (epirubicin, cyclophosphamide, and paclitaxel) affect the heart over time. Researchers planned to use advanced heart imaging to detect early signs of damage, but the study was terminated after enrolling only 2 participants. No results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut de cancérologie Strasbourg Europe
Strasbourg, France, 67033, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.